Monterola, NiƱo O.

HRN: 28-99-28  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/27/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/27/2026
06/03/2026
IV
600 Mg
Q6h
S/P ORIF MANDIBLE
Checking Initial Appropriateness 

Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: Compliant To Guidelines